Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of tetrandrine in preparation of leukemia multidrug resistance (MDR) reversal agent

A technology of tetrandrine and multidrug resistance, which is applied in the field of biomedicine, can solve the problems of no specific target, weak curative effect, low toxicity and side effects, etc., and achieve the reversal of tumor multidrug resistance and inhibition of multidrug resistance on the cell surface. Synthesis of the drug-resistant protein P-glycoprotein, which enhances the effect of chemotherapy

Inactive Publication Date: 2015-03-11
SOUTHEAST UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, they have no specific target, and mainly inhibit the pumping of cytotoxic drugs through competitive action, so it is necessary to increase the drug concentration of these reversal agents, and these doses are often beyond their production in the body Minimum dose for toxic effects
The second-generation reversal agents mainly include dexverapamil, dexniguldipine, cyclosporine analogs valspodar (PSC833) and biricodar (VX2710) ), etc., have lower toxic and side effects than the first generation, while the activity of reversing MDR is significantly enhanced, but their influence on the pharmacokinetics of chemotherapy drugs has become a major obstacle in clinical application
However, most of the traditional Chinese medicine reversal agents found so far have weak curative effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of tetrandrine in preparation of leukemia multidrug resistance (MDR) reversal agent
  • Application of tetrandrine in preparation of leukemia multidrug resistance (MDR) reversal agent
  • Application of tetrandrine in preparation of leukemia multidrug resistance (MDR) reversal agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1: Effects of Tet combined with daunorubicin (DNR) on the proliferation of human chronic myelogenous leukemia acute erythroleukemia cell line K562 and its drug-resistant strain K562 / A02 in vitro.

[0016] The tetrandrine used is a commercially pure product (purity>98%).

[0017] Cells in the logarithmic growth phase were seeded in a 96-well plate, each well containing 2×10 4 160uL of cell suspension, add different concentrations of tetrandrine (0mg / L, 0.5mg / L, 1.0mg / L, 2.0mg / L) to each plate for 1 hour, then add different concentrations of soft red according to the set gradient Mycin (final concentration 50mg / L, 25mg / L, 12.5mg / L, 6.25mg / L, 3.125mg / L, 1.5625mg / L and 0.78125mg / L), each daunorubicin concentration set 5 complex hole. A control group without reversal agent, daunorubicin, and cells was also set up, and the volume of each well was adjusted to 200uL. Placed at 37°C, 5% CO 2 After 48 hours of incubation in the incubator, take it out, add 20ul of 5m...

Embodiment 2

[0020] Example 2 Detection of P-glycoprotein (P-glycoprotein, P-gp) expression on the surface of leukemia drug-resistant cells K562 / A02 by flow cytometry

[0021] Cells were divided into groups by adding Tetrandrine at the set concentration (0mg / L, 0.5mg / L, 1.0mg / L, 2.0mg / L), at 37°C, 5% CO 2 After incubation in the incubator for 48 hours, the cells were harvested. The cells of each experimental group were concentrated by centrifugation (the number of cells in each group was 1×10 6 ), washed 3 times with cold PBS, centrifuged at 1500 rpm for 5 minutes, discarded the supernatant, and added 5 μl of P-gp monoclonal antibody (labeled with fluorescein PE). Protect from light and store at room temperature for 20 minutes, then wash once with normal saline, centrifuge at 1500 rpm for 5 minutes, discard the supernatant, add 0.5ml of normal saline, and perform flow cytometry detection.

[0022] The results showed that after Tetrandrine (0mg / L, 0.5mg / L, 1.0mg / L, 2.0mg / L) acted on the...

Embodiment 3

[0023] Example 3 Semi-quantitative reverse transcriptase polymerase chain reaction (reverse transcript polymase chain reaction, RT-PCR) method to detect multidrug resistance gene 1 (multidrug resistance 1, mdr1) mRNA expression level

[0024] Take K562 / A02 cells (final concentration 2×10 4 mL, 4mL for each group), add the set final concentration of Tetrandrine (0mg / L, 0.5mg / L, 1.0mg / L, 2.0mg / L) in groups, at 37℃, 5% CO 2Cells were cultured in an incubator and harvested after 48 hours. TRIzol (invitrogen) was used to extract total RNA in one step, and the mdr1 gene fragment (436 bp) and β-actin gene fragment (270 bp) were amplified according to the instructions of the RT-PCR kit (Dalian Bao Biological Engineering Co., Ltd.), and the upstream primer of mdr1 (SEQ ID NO:1) 5'-TGGTTTGATGTGCACGATGTTGGG-3'; mdr1 downstream primer (SEQ ID NO:2) 5'-AGATCAGCAGGAAAGCAGCACCTA-3'; β-actin upstream primer (SEQ ID NO:3) 5'-ACACTGTGCCCATCTACGAGGGG- 3'; β-actin downstream primer (SEQ ID NO...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of tetrandrine in the preparation of a leukemia multidrug resistance (MDR) reversal agent. Tetrandrine is used to treat drug resistant leukemia in the assistance of antharcycline chemotherapy drugs. In a low concentration range of 0.5 to 2.0 mg / L, the tetrandrine can enhance the inhibiting effect of daunorubicin on drug resistant cells, while the inhibiting effect on sensitive cells is basically not changed at the same time. The tetrandrine can inhibit the amplification of the MDR gene mdr-1, and thus inhibit the synthesis of MDR protein (P-glycoprotein) on the cell surface. Small dosage of tetrandrine can enhance the inhibiting effect of antharcycline chemotherapy drugs on drug-resistant leukemia so as to avoid the severe side and toxic effect due to the single application of chemotherapy drugs, and the application range of tetrandrine is enlarged.

Description

technical field [0001] The invention belongs to the technical field of biomedicine and relates to the application of tetrandrine as a drug resistance reversal agent for leukemia. Background technique [0002] In recent years, the induction remission rate of acute leukemia has been increasing day by day, but 20% to 40% of patients still cannot achieve complete remission, and most remission patients have relapsed one after another. The occurrence of multidrug resistance is the main reason for the relapse of leukemia patients. reason. Therefore, the prevention and reversal of clinical multidrug resistance has become an urgent problem in cancer treatment, and it is also a hot and difficult area of ​​research. [0003] Multidrug resistance (MDR) refers to the resistance to a certain cytotoxic drug after the drug-resistant cell line is exposed to one or several drugs, not only develops resistance to the drug, but also to many structurally unrelated and Other anticancer drugs wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4748A61P35/02
CPCA61K31/4748
Inventor 陈宝安王飞程坚李静
Owner SOUTHEAST UNIV